Back to search

Article

A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy

2024-06-03

Abstract excerpt

<h4>Background</h4> Prostate cancer is a heterogenous disease, but once it becomes metastatic it eventually becomes treatment resistant. One mechanism of resistance to AR-targeting therapy is lineage plasticity, where the tumor undergoes a transformation to an AR-indifferent phenotype, most studied in the context of neuroendocrine prostate cancer (NEPC). However, activation of additional de- or trans-differentiat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec8339a0-6061-599b-b274-ded093c1ca66
DOI
10.1101/2024.06.02.595931
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapyDOI 10.1101/2024.06.02.595931
Select a neighboring publication to make it the new centre.